Skip to main content
SPRY
NASDAQ Life Sciences

Q3 Revenue Climbs to $37.7M as Net Loss Narrows and SG&A Drops 42%

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.65
Mkt Cap
$263.535M
52W Low
$2.59
52W High
$13.15
52W Position info
2.3% above low
Off High info
80% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

SPRY is trading near its 52-week low of $2.59 (2.3% above the low).

Summary

ARS Pharma posted Q3 2026 total revenue of $37.7 million, up from $32.5 million a year ago, with neffy U.S. net product revenue of $33.4 million versus $31.3 million. The net loss narrowed to $35.6 million, or $(0.36) per share, from $51.2 million a year earlier, and SG&A fell to $43.5 million from $74.8 million after the company killed linear TV and broad consumer advertising — a 42% reduction from the first-half 2026 quarterly average. neffy's total U.S. market share reached 5% (up from 4%) and about 9% in field-targeted accounts, which the company says represent roughly 44% of the market opportunity. Cash stood at $138.4 million as of September 30, and management reaffirmed its path to cash flow breakeven by the end of 2027. The stock sits near its 52-week low, so the cost discipline and narrowed loss are the key items; ARS-2 interim Phase 2b data in Q1 2027 is the next scheduled readout.

At the time of this announcement, SPRY was trading at $2.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $263.5M. The 52-week trading range was $2.59 to $13.15. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SPRY - Latest Insights

SPRY
Nov 05, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.65
Real-time Price: $3.87 info
Change: +$1.22 (+46%) info
Market Cap: $397.087M info
SPRY
Nov 05, 2026, 4:04 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.65
Real-time Price: $3.87 info
Change: +$1.22 (+46%) info
Market Cap: $397.087M info
SPRY
Aug 13, 2026, 4:13 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $5.31
Real-time Price: $3.87 info
Change: -$1.44 (-27%) info
Market Cap: $397.087M info
SPRY
Aug 13, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.32
Real-time Price: $3.87 info
Change: -$1.45 (-27%) info
Market Cap: $397.087M info
SPRY
Aug 13, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.12
Real-time Price: $3.87 info
Change: -$1.25 (-24%) info
Market Cap: $397.087M info